PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fooladi AA et al. – The data suggest that MPL is a suitable adjuvant that probably leads to more sustained effect of SEB. Because the results of our cytokine assay indicate that the level of IFN–g compared with IL–4, SEB + MPL could be a candidate for tumor therapy.

   

Today in Infectious Disease...keeping you current

Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
The Journal of Headache and Pain, 11/25/09

Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09

Emergency Influenza Drug
JAMA, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address